Preliminary studies have explored the potential role of the circadian clock in regulating the dedifferentiation program utilized by aggressive and invasive tumor cells to metastasize from primary to secondary sites and initiate recurrent tumors. The gene discussed is CLOCK; the disease is neoplasm.